ALS treatment to begin Phase 3 clinical trials in US BrainStorm Cell Therapeutics’ NurOwn platform enhances a patient’s own adult stem cells to halt progression of incurable neurodegenerative diseases.
Revolutionary stem-cell ALS treatment begins advanced trials BrainStorm’s NurOwn enhanced adult stem cells seem to halt the progression of incurable neurodegenerative diseases.